Cargando…
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization
Autores principales: | Hohaus, Stefan, Tisi, Maria Chiara, Bartolomei, Francesca, Cuccaro, Annarosa, Maiolo, Elena, Alma, Eleonora, D’Alò, Francesco, Bellesi, Silvia, Rossi, Elena, De Stefano, Valerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993802/ https://www.ncbi.nlm.nih.gov/pubmed/29884791 http://dx.doi.org/10.1038/s41408-018-0096-1 |
Ejemplares similares
-
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
por: Hohaus, Stefan, et al.
Publicado: (2020) -
Vitamin D deficiency and supplementation in patients with aggressive B‐cell lymphomas treated with immunochemotherapy
por: Hohaus, Stefan, et al.
Publicado: (2017) -
Severe CMV Infection after Chemo-Immunotherapy with Dose-Reduced Bendamustine and Rituximab in a Mantle Cell Lymphoma Old Patient
por: Magliano, Gabriele, et al.
Publicado: (2021) -
PD‐L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2022) -
P1091: CLINICAL IMPLICATIONS OF T CELL SUBSET COMPOSITION DURING MAINTENANCE THERAPY AFTER FIRST-LINE IMMUNOCHEMOTHERAPY CONTAINING BENDAMUSTINE IN PATIENTS WITH FOLLICULAR LYMPHOMA
por: Malafronte, Rosalia, et al.
Publicado: (2023)